Amgen's Decline May Be Linked To Comments Of Express Script's CEO

Shares of Amgen, Inc. AMGN began moving lower Tuesday afternoon.

The price action may be due to comments made by George Paz, CEO of Express Scripts Holding Company ESRX, at the JP Morgan Healthcare conference that cholesterol drugs may be its next focus for negotiating discounts.

Express Scripts recently chose AbbVie Inc ABBV as its exclusive supplier for treatment of hepatitis C, which some analysts expected could lead to a price war.

Amgen gave up gains from earlier in the day and recently traded at $156.46, up 0.88 percent.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsRumorsIntraday UpdateJP Morgan
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!